Serial Studies of Immunocompetence of Patients Undergoing Chemotherapy for Acute Leukemia

E. M. Hersh; J. U. Gutterman; G. M. Mavligit; K. B. McCredie; M. A. Burgess; A. Matthews; E. J. Freireich

doi:10.1172/JCI107775

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by Hersh, E. in: PubMed | Google Scholar

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by Gutterman, J. in: PubMed | Google Scholar

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by Mavligit, G. in: PubMed | Google Scholar

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by McCredie, K. in: PubMed | Google Scholar

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by Burgess, M. in: PubMed | Google Scholar

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by Matthews, A. in: PubMed | Google Scholar

^{Department of Developmental Therapeutics, The Unviersity of Texas System Cancer Center, M. D. Anderson Hospital, Houston, Texas 77025}

^{Tumor Institute at Houston, Houston, Texas 77025}

Find articles by Freireich, E. in: PubMed | Google Scholar

Published in Volume 54, Issue 2 on August 1, 1974
J Clin Invest. 1974;54(2):401–408. https://doi.org/10.1172/JCI107775.
© 1974 The American Society for Clinical Investigation

Published August 1, 1974 - Version history

Immunocompetence was followed serially for 1 yr from the onset of treatment in 55 adult patients with acute leukemia. The tests used were delayed hypersensitivity responses to a battery of five recall antigens (dermatophytin, dermatophytin 0, candida, streptokinase-streptodornase, and mumps) and in vitro lymphocyte blastogenic responses to phytohemagglutinin and streptolysin 0. There was a strong correlation between immunocompetence at the start of treatment and a good prognosis; 32/39 patients who subsequently entered remission were initially immunocompetent compared to 4/15 who failed to enter remission. In the complete remission group there was a decline in competence starting from 2 to 5 mo after the onset of treatment. In those who remained in remission for 1 yr, competence recovered at 6 mo and remained vigorous thereafter. In those who relapsed before 1 yr, the decline in competence occurred 1 mo before relapse and competence continued to decline progressively during the 1 yr follow-up period. These studies suggest that therapeutic approaches which restore immunocompetence or prevent its decline will improve both the remission rate and the remission duration of patients with acute leukemia.

Version 1 (August 1, 1974): No description

Serial Studies of Immunocompetence of Patients Undergoing Chemotherapy for Acute Leukemia

E. M. Hersh, J. U. Gutterman, G. M. Mavligit, K. B. McCredie, M. A. Burgess, A. Matthews, and E. J. Freireich

Article tools

Metrics

Go to

Serial Studies of Immunocompetence of Patients Undergoing Chemotherapy for Acute Leukemia

E. M. Hersh, J. U. Gutterman, G. M. Mavligit, K. B. McCredie, M. A. Burgess, A. Matthews, and E. J. Freireich

Article tools

Metrics

Go to

Sign up for email alerts